Elon Musk's efforts to slash spending at the US government could start to weigh on Tesla vehicle sales, according to Stephen Gengaro, a research analyst at Stifel. In a note over the weekend ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

Outside of electric vehicles, Tesla is building a new business featuring humanoid robots. These robots, called Optimus, represent an important pillar in Tesla's AI vision. Musk recently shared ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Although President Trump has also said he plans to end EV tax credits, Gengaro says this would still leave Tesla as a profitable EV maker. To watch more expert insights and analysis on the latest ...

Like him or hate him, Elon Musk’s companies are constantly making headlines and few companies create a greater diversity of opinion than his electric car manufacturer, Tesla Inc. (NASDAQ ...